CSPG4P12, as a pseudogene of CSPG4, has been reported to inhibit non-small cell lung cancer (NSCLC) development and tumorigenesis by activating the p53/Bcl2/Bax mitochondrial apoptotic pathway in our previous study (14). Here, BCL2 is linked to non-small cell lung carcinoma.